Brixton Biosciences Adds Leaders Ahead of Reneurx Launch
Cambridge, Massachusetts, August 18, 2026 Brixton Biosciences has strengthened its Board of Directors with the appointment of three experienced...
Knee Osteoarthritis
Advertisement
Pacira BioSciences Publishes Two-Year Phase 1 PCRX-201 Knee OA Data
BRISBANE, Calif., August 6, 2026 Pacira BioSciences announced the publication of positive two-year Phase 1 clinical trial results for...
Pathos AI Partners with AstraZeneca to Advance AZD4241 for ER+ Breast Cancer
NEW YORK, Aug. 4, 2026 Pathos AI announced a collaboration and co-exclusive licensing agreement with AstraZeneca to advance AZD4241,...
4Moving Biotech Targets Synovitis with Intra-Articular GLP-1 Therapy
LILLE & PARIS, France, Aug. 4, 2026 4Moving Biotech (4MB) announced the completion of patient enrollment in the Phase...
Levicept’s LEVI-04 Shows Disease-Modifying Potential in Osteoarthritis
SANDWICH, UK, June 3, 2026 Levicept Ltd announced new data from its Phase 2 clinical trial of LEVI-04, a...
Advertisements
OrthoTrophix TPX-100 Shows Breakthrough in Knee OA Study
Foster City, California | April 24, 2026 OrthoTrophix has unveiled compelling new clinical findings highlighting the structural relationship between...
OvertureTi Knee System Reaches $1M Sales Milestone
Irvine, California | December 30, 2025 — Overture Orthopaedics, a U.S.-based medical device company specializing in joint preservation technologies,...
MEDIPOST Secures Japan Commercial Deal for CARTISTEM® Therapy
Seoul, South Korea, December 19, 2025 — MEDIPOST Co., Ltd., a fully integrated cell therapy biotechnology company, has entered...
NEXTBIOMEDICAL Launches U.S. Pivotal Trial for Nexsphere-F™ in Knee OA
SEOUL, South Korea, Oct. 13, 2025 — NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), a South Korea-based innovative medical device company,...
Advertisement
